Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Experimental Cell Research|October 24, 2021
HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2Juan Li, Meixiang Sang, Yang Zheng, et al.Archives of Medical Research|July 1, 2016
Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA MicroarrayMeixiang Sang, Lina Gu, Fei Liu, et al.International Journal of General Medicine|August 28, 2023
KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine TherapyXuchen Huang, Sainan Li, Wei Gao, et al.Molecular Therapy. Nucleic Acids|September 11, 2020
ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling PathwayLingjiao Meng, Sihua Liu, Fei Liu, et al.Carcinogenesis|June 13, 2020
Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinomaYunyan Wu, Meixiang Sang, Fei Liu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2017
Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 PeptideJiandong Zhang, Meixiang Sang, Lina Gu, et al.Journal of Clinical Pathology|November 20, 2016
MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarrayMeixiang Sang, Lina Gu, Danjing Yin, et al.Life Sciences|August 22, 2012
LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53Xinliang Zhou, Meixiang Sang, Wei Liu, et al.Cancers|December 11, 2022
circRNF10 Regulates Tumorigenic Properties and Natural Killer Cell-Mediated Cytotoxicity against Breast Cancer through the miR-934/PTEN/PI3k-Akt AxisFei Liu, Yang Sang, Yang Zheng, et al.Oncotarget|February 10, 2018
MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growthShina Liu, Fei Liu, Weina Huang, et al.Pageof 9